Teladoc Health/$TDOC
1D1W1MYTD1Y5YMAX
Capital at risk
About Teladoc Health
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
- Ticker
- $TDOC
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 5,124
- Headquarters
- New York, United States
- Website
- www.teladochealth.com
Teladoc Health Metrics
BasicAdvanced
$1.1B
-
-$0.99
2.13
-
Price and volume
Market cap
$1.1B
Beta
2.13
52-week high
$9.89
52-week low
$4.40
Average daily volume
4M
Financial strength
Current ratio
0.831
Quick ratio
0.728
Long term debt to equity
2.255
Total debt to equity
78.332
Interest coverage (TTM)
-7.30%
Profitability
EBITDA (TTM)
53.137
Gross margin (TTM)
68.97%
Net profit margin (TTM)
-7.13%
Operating margin (TTM)
-5.85%
Effective tax rate (TTM)
2.85%
Revenue per employee (TTM)
$490,000
Management effectiveness
Return on assets (TTM)
-3.22%
Return on equity (TTM)
-12.99%
Valuation
Price to revenue (TTM)
0.442
Price to book
0.85
Price to tangible book (TTM)
-7.52
Price to free cash flow (TTM)
9.32
Free cash flow yield (TTM)
10.73%
Free cash flow per share (TTM)
0.661
Growth
Revenue change (TTM)
-2.08%
Earnings per share change (TTM)
-16.91%
3-year revenue growth (CAGR)
-0.55%
10-year revenue growth (CAGR)
38.48%
3-year earnings per share growth (CAGR)
-65.74%
10-year earnings per share growth (CAGR)
-4.26%
What the Analysts think about Teladoc Health
Analyst ratings (Buy, Hold, Sell) for Teladoc Health stock.
Analyst projections of the future price of Teladoc Health stock.
Bulls say / Bears say
Integrated Care revenue held essentially flat at $394 million versus $392 million a year earlier, demonstrating resilience in the core virtual medical services business (Investing.com)
Chronic care program enrollment grew 13.9% year-over-year to 1.272 million, highlighting strong uptake in high-value condition management services (Teladoc Q2 metrics)
Integrated Care adjusted EBITDA margin expanded to 16.5% from 14.7% in the prior-year quarter, reflecting operational efficiency gains (Teladoc Q2 metrics)
BetterHelp segment revenue declined 12% year-over-year to $212.6 million, weighing on Teladoc’s top-line growth (Teladoc Q2 release)
Teladoc cut its full-year 2026 revenue guidance midpoint by roughly 5% to $2.405 billion, reflecting persistent weakness in its mental health business (Reuters)
BetterHelp paying users fell 10.8% to 346 000 in Q2, underscoring challenges in retaining cash-pay consumers amid the segment’s shift to insurance (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 26 Aug 2026.
Teladoc Health Financial Performance
Revenues and expenses
Teladoc Health Earnings Performance
Company profitability
Upcoming events
No upcoming events
Teladoc Health News
AllArticlesVideos
Teladoc appoints insurance executive Michael Grasher as CFO
Reuters2 weeks ago
Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Business Wire1 month ago
Teladoc Stock Plummets on Revenue Miss, Lowered Outlook
Schaeffers Research1 month ago
Funds containing Teladoc Health
AllEURUSDGBP
Fund name | Fund size | $TDOC weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.14% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.04% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.01% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.